Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone medicines, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The Global Endometriosis Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.6% CAGR during the forecast period.
Market Growth Factors
Government efforts to raise endometriosis awareness
Establishing referral networks and care pathways with advanced imaging, pharmaceutical, surgical, fertility, and multidisciplinary interventions at tertiary and secondary centers with good connections to primary healthcare facilities. Increasing the availability of tools (such as ultrasound or magnetic resonance imaging) and medications will help health systems be better equipped to detect and treat endometriosis early (e.g., combined oral contraceptives, non-steroidal analgesics, and progestin-based contraceptives).
The market growth will be boosted by numerous significant governmental entities conducting programs and other awareness initiatives. This would increasingly support the market growth during the projection period.
Increasing incidence of gynecological disorders such as endometriosis
Endometriosis is a condition in which tissue that resembles the uterine lining grows outside of the uterus, resulting in pain and/or infertility. Around 10% (190 million) of women and adolescents of reproductive age suffer from endometriosis worldwide. It is a chronic condition that causes excruciating, life-altering agony during periods, sexual activity, bowel and/or bladder movements, chronic pelvic discomfort, stomach bloating, nausea, exhaustion, and occasionally depression, anxiety, and infertility.
Market Restraining Factor
The absence of non-invasive endometriosis diagnostic tests
A diagnostic test's usefulness and validity are primarily determined by its sensitivity and specificity for a certain ailment. However, it can occasionally be challenging to comprehend and apply these measures to clinical decision-making. The likelihood that a positive or negative test would properly identify whether a patient has the condition is known as the positive predictive value (PPV) or negative predictive value (NPV). The endometriosis market is predicted to experience slow expansion due to the absence of appropriate and efficient diagnosis devices.
Type Outlook
Based on type, the endometriosis market is segmented into superficial peritoneal lesion, endometriomas and others. The superficial peritoneal lesion segment generated the highest revenue share in the endometriosis market in 2021. This is a result of the increase in the incidence of superficial peritoneal lesions and the creation of programs to raise endometriosis awareness. Additionally, a rise in government financing for endometriosis research has accelerated the development of the superficial peritoneal lesion segment.
Distribution Channel Outlook
On the basis of distribution channel, the endometriosis market is categorized into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment witnessed the largest revenue share in the endometriosis market in 2021. This is due to an expansion in hospital pharmacies and a rise in patients' confidence in hospitals as providers of high-quality care. The hospital pharmacy market is primarily driven by the growing trend of endometriosis therapy as an alternative to surgery. Hospital pharmacists can also help endometriosis patients, and their carers choose the right medications because they are knowledgeable about medications. Such elements all encourage sector expansion.
Treatment Outlook
By treatment, the endometriosis market is bifurcated into oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines and others. The gonadotropin-releasing hormone (GnRH) medicines segment recorded a prominent revenue share in the endometriosis market in 2021. They are available as a tablet, injection, shot, or nasal spray. Orilissa (elagolix), manufactured by AbbVie Inc., was the first drug given FDA approval to alleviate disease-related pain. Patients who are resistant to the first line of treatment should consider GnRH agonists and antagonists as alternatives.
Regional Outlook
Region wise, the endometriosis market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region dominated the endometriosis market with maximum revenue share in 2021. This is mostly linked to an increase in endometriosis cases, which necessitate additional treatments such as gonadotropin-releasing hormone (GnRH) medications, an increase in government financing for endometriosis research, and a considerable increase in capital income in developed countries. The sophisticated reimbursement structures that exist and are designed to lower expenditure levels also contribute to the market's expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
Key Market Players
List of Companies Profiled in the Report:
- Teva Pharmaceuticals Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Sanofi S.A
- AbbVie, Inc
- AstraZeneca PLC
- Pfizer, Inc
- Merck & Co., Inc
- GlaxoSmithKline PLC
- Abbott Laboratories
- Consilient Health Limited
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 204 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value (USD) in 2021 | $1046.3 Million |
| Forecasted Market Value (USD) by 2028 | $2237.8 Million |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Global Endometriosis Market by Type
Chapter 4. Global Endometriosis Market by Treatment
Chapter 5. Global Endometriosis Market by Distribution Channel
Chapter 6. Global Endometriosis Market by Region
Chapter 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/a4ha3t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
